Endotoxemia: Clinical Trials

1 trial for Endotoxemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Endotoxemia: new trials by email Literature Review of Endotoxemia trials Research Report on Endotoxemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes
Rifaximin, Placebo - Liver Cirrhosis, Coagulation Disorder
Phase 4TerminatedUniversity of Roma La Sapienza202021-04-032024-10-08

Narrower conditions

Blood Platelet Disorders (1)  ·  Hemostatic Disorders (1)  ·  Liver Cirrhosis (1)

Broader conditions

Bacteremia (1)  ·  Cardiovascular Diseases (1)  ·  Digestive System Diseases (1)  ·  Fibrosis (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Toxemia (1)

Interventions

Rifaximin (1)

Sponsors

University of Roma La Sapienza (1)

Countries

Italy (1)

Top investigators

Lucia Stefanini, Prof. (1)  ·  Manuela Merli, Prof. (1)  ·  Oliviero Riggio, Prof. (1)  ·  Roberto Carnevale, Prof. (1)